Compounds > atorvastatin
Page last updated: 2024-08-24

atorvastatin and Age-Related Memory Disorders

atorvastatin has been researched along with Age-Related Memory Disorders in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (23.08)29.6817
2010's8 (61.54)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Ge, X; Shi, M; Tai, Y; Tian, J; Xu, W; Zhao, C; Zhu, G1
Atasoy, Ö; Erbaş, O; Solmaz, V1
Dehpour, AR; Honarmand, AR; Javadi-Paydar, M; Pourtabatabaei, N; Rahimi, N1
Jin, Y; Liang, B; Qu, WH; Sui, HJ; Wang, HM; Yu, SX; Zhang, LL1
Bezerra, SC; de Bem, AF; Duarte, FS; Figueiredo, CP; Mancini, G; Piermartiri, TC; Prediger, RD; Rial, D; Tasca, CI1
Akgün-Dar, K; Aksu, U; Uzüm, G1
Bouwels, L; de Leeuw, FE; Enajat, M; Pop, G; Pop-Purceleanu, M; Tendolkar, I; van Kuilenburg, J; van Wingen, G; Zwiers, MP1
Dehpour, AR; Fakhraei, N; Javadi-Paydar, M; Mirazi, N; Norouzi, A; Rayatnia, F; Zakeri, M1
Allami, N; Dehpour, AR; Javadi-Paydar, M; Norouzi, A; Rastegar, H; Rayatnia, F; Zakeri, M1
Hennessey, MJ; Murphy, SM; Ryan, D1
Harrell, TK; Jones, DW; King, DS; Lindley, BJ; Wilburn, AJ; Wofford, MR1
Chen, J; Chopp, M; Goussev, A; Jiang, H; Li, Y; Lu, C; Lu, D; Mahmood, A; Qu, C; Schallert, T1

Trials

1 trial(s) available for atorvastatin and Age-Related Memory Disorders

ArticleYear
One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial.
    International journal of geriatric psychiatry, 2012, Volume: 27, Issue:1

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; Atrophy; Azetidines; Biomarkers; Cholesterol; Double-Blind Method; Ezetimibe; Female; Heptanoic Acids; Humans; Male; Memory; Memory Disorders; Neuropsychological Tests; Pyrroles; Temporal Lobe

2012

Other Studies

12 other study(ies) available for atorvastatin and Age-Related Memory Disorders

ArticleYear
Atorvastatin Relieves Cognitive Disorder After Sepsis Through Reverting Inflammatory Cytokines, Oxidative Stress, and Neuronal Apoptosis in Hippocampus.
    Cellular and molecular neurobiology, 2020, Volume: 40, Issue:4

    Topics: Animals; Anxiety; Apoptosis; Astrocytes; Atorvastatin; Behavior, Animal; Cecum; Cognition Disorders; Cytokines; Glial Fibrillary Acidic Protein; Hippocampus; Inflammation Mediators; Learning; Ligation; Male; Memory Disorders; Mice, Inbred ICR; Morris Water Maze Test; Motor Activity; Neurons; Oxidative Stress; Punctures; Sepsis; Survival Analysis

2020
Atorvastatin has therapeutic potential for the fatty liver-induced memory dysfunction in rats, likely via its antioxidant and anti-inflammatory properties.
    Neurological research, 2020, Volume: 42, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Atorvastatin; Brain; Fatty Liver; Inflammation; Male; Memory Disorders; Oxidative Stress; Rats; Rats, Sprague-Dawley

2020
Suppression of memory acquisition following co-administration of lithium and atorvastatin through nitric oxide pathway in mice.
    Pharmacology, biochemistry, and behavior, 2014, Volume: 122

    Topics: Animals; Atorvastatin; Avoidance Learning; Dose-Response Relationship, Drug; Heptanoic Acids; Lithium; Male; Memory; Memory Disorders; Mice; Nitric Oxide; Pyrroles; Signal Transduction

2014
Atorvastatin prevents amyloid-β peptide oligomer-induced synaptotoxicity and memory dysfunction in rats through a p38 MAPK-dependent pathway.
    Acta pharmacologica Sinica, 2014, Volume: 35, Issue:6

    Topics: Amyloid beta-Peptides; Animals; Anticholesteremic Agents; Atorvastatin; Cells, Cultured; Heptanoic Acids; Hippocampus; Male; Maze Learning; Memory Disorders; Neurons; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction; Synapses

2014
Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage.
    Experimental neurology, 2010, Volume: 226, Issue:2

    Topics: Amino Acid Transport System X-AG; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Atorvastatin; Cell Death; Cyclooxygenase 2; Encephalitis; Fluoresceins; Gene Expression Regulation; Glutamic Acid; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Heptanoic Acids; Hippocampus; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Learning Disabilities; Male; Maze Learning; Memory Disorders; Mice; Nerve Tissue Proteins; Neurons; Organic Chemicals; Oxidative Stress; Peptide Fragments; Propidium; Pyrroles; Tritium

2010
The effects of atorvastatin on memory deficit and seizure susceptibility in pentylentetrazole-kindled rats.
    Epilepsy & behavior : E&B, 2010, Volume: 19, Issue:3

    Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Atorvastatin; Avoidance Learning; Disease Susceptibility; Electroencephalography; Heptanoic Acids; Kindling, Neurologic; Male; Memory Disorders; Pentylenetetrazole; Pyrroles; Rats; Rats, Wistar; Reaction Time; Seizures

2010
Atorvastatin improved scopolamine-induced impairment in memory acquisition in mice: involvement of nitric oxide.
    Brain research, 2011, Apr-22, Volume: 1386

    Topics: Animals; Arginine; Atorvastatin; Cholinergic Antagonists; Disease Models, Animal; Enzyme Inhibitors; Guanidines; Heptanoic Acids; Learning Disabilities; Memory; Memory Disorders; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pyrroles; Scopolamine

2011
Nitric oxide involvement in consolidation, but not retrieval phase of cognitive performance enhanced by atorvastatin in mice.
    European journal of pharmacology, 2011, Volume: 666, Issue:1-3

    Topics: Animals; Arginine; Atorvastatin; Cognition; Drug Antagonism; Drug Synergism; Guanidines; Heptanoic Acids; Memory; Memory Disorders; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pyrroles; Scopolamine; Spatial Behavior

2011
Bilateral posterior cerebral artery infarction.
    BMJ case reports, 2010, Dec-01, Volume: 2010

    Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Confusion; Dominance, Cerebral; Drug Therapy, Combination; Fibrinolytic Agents; Hemianopsia; Heptanoic Acids; Humans; Infarction, Posterior Cerebral Artery; Magnetic Resonance Imaging; Male; Memory Disorders; Memory, Short-Term; Perindopril; Pyrroles; Tomography, X-Ray Computed

2010
Cognitive impairment associated with atorvastatin and simvastatin.
    Pharmacotherapy, 2003, Volume: 23, Issue:12

    Topics: Aged; Atorvastatin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Memory Disorders; Pyrroles; Simvastatin

2003
Statins don't stop aortic valve narrowing...or memory loss (yet).
    Harvard heart letter : from Harvard Medical School, 2005, Volume: 16, Issue:1

    Topics: Aortic Valve Stenosis; Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Memory Disorders; Pyrroles; Treatment Failure

2005
Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury.
    Journal of neurotrauma, 2007, Volume: 24, Issue:7

    Topics: Animals; Atorvastatin; Brain Injuries; Cell Proliferation; Dentate Gyrus; Dose-Response Relationship, Drug; Heptanoic Acids; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Maze Learning; Memory Disorders; Neovascularization, Physiologic; Nerve Degeneration; Nerve Regeneration; Neuronal Plasticity; Neurons; Neuroprotective Agents; Pyrroles; Rats; Rats, Wistar; Recovery of Function; Simvastatin; Stem Cells; Treatment Outcome

2007